22nd Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

  • 12-14 December 2024丨USA
  • 29 Feb 2024
Media Partnership

between Cardiovascular Science and the 22nd Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)



The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 22nd year, is a unique and exciting multidisciplinary CME conference. The program is designed to evaluate both clinical and basic science aspects of diabetes, obesity, CVD, and CKD, focusing on insulin resistance, incretins, the gut, the brain, the kidney, and the heart in pursuit of our theme: Exploring New Frontiers in Metabolism — Tomorrow’s Clinical Science Today. The goal is to understand the pathophysiology and develop the appropriate comprehensive clinical management plans. This educational initiative is designed for endocrinologists, cardiologists, nephrologists, family physicians, internists, diabetologists, gastroenterologists, pediatricians, OB/GYN, researchers, nurse practitioners, physician assistants, dieticians, diabetes educators, and other healthcare professionals interested in the pathophysiology, prevention, and treatment of diabetes, obesity, CVD, CKD, HF, and associated conditions, as well as the effect of these conditions on health and society.

Registration: https://www.wcir.org/registration-2024